ALLURION TECHNOLOGIES, INC.

Offers a swallowable gastric balloon & digital platform for non-surgical weight loss.

ALUR | NYSE

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 11 HURON DR STE 200, 1760 NATICK
Website:: https://www.allurion.com/en
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Allurion Technologies, Inc. is a medical technology company dedicated to ending obesity. The company develops and markets the Allurion Program, a comprehensive weight-loss platform centered around the world's first and only swallowable, procedure-less gastric balloon. The program integrates the medical device with a full digital ecosystem, including the Allurion App, a Connected Scale, and an AI-powered coach, to provide real-time tracking and support. This is combined with professional nutritional coaching and medical supervision over a minimum six-month period. The platform is designed to help patients achieve and maintain metabolically healthy weight loss without surgery or endoscopy, and is available through a global network of partner clinics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ALLURION TECHNOLOGIES, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ALLURION TECHNOLOGIES, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ALLURION TECHNOLOGIES, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Noul Co., Ltd. AI-powered, automated point-of-care diagnostics for accessible global healthcare.	South Korea	376930
Nuwellis, Inc. Develops an ultrafiltration system to remove excess fluid from diuretic-resistant patients.	United States of America	NUWE
Nyxoah SA Develops a mask-free, minimally invasive neurostimulation implant to treat Obstructive Sleep Apnea.	United States of America	NYXH
OMNICELL, INC. Automating medication management for healthcare providers with robotics and intelligent software.	United States of America	OMCL
ONCOSEM ONKOLOJİK SİSTEMLER SANAYİ VE TİCARET A.Ş. Manufactures automated systems & devices for safe, efficient oncology chemotherapy treatment.	Türkiye	ONCSM
Ondine Biomedical Inc. Develops photodisinfection therapies to combat antimicrobial resistance and prevent infections.	Canada	OBI
Onward Medical N.V. Develops spinal stimulation therapies to restore movement for people with spinal cord injury.	Netherlands	ONWD
Orchestra BioMed Holdings, Inc. Develops bioelectronic & drug/device therapies for hypertension and artery disease.	United States of America	OBIO
Organogenesis Holdings Inc. Develops regenerative biomaterials for wound care, surgical, and sports medicine markets.	United States of America	ORGO
Orthofix Medical Inc. Delivering musculoskeletal solutions like spinal hardware & biologics to global health providers.	United States of America	OFIX